Thomas A. Dix
Corporate Officer/Principal en Medical University of South Carolina .
Perfil
Thomas A.
Dix is a Director and Chief Scientific Officer of Argolyn Bioscience, Inc. He is an Associate Professor of Pharmaceutical Sciences in the College of Pharmacy at the Medical University of South Carolina.
Previously, he was an Assistant Professor in the Departments of Chemistry and Biological Chemistry at the University of California, Irvine.
Dr. Dix received a PhD in Chemistry from Wayne State University.
Cargos activos de Thomas A. Dix
| Empresas | Cargo | Inicio |
|---|---|---|
| Medical University of South Carolina | Corporate Officer/Principal | 27/05/2009 |
Antiguos cargos conocidos de Thomas A. Dix.
| Empresas | Cargo | Fin |
|---|---|---|
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Fundador | 26/11/2009 |
| University of California, Irvine | Corporate Officer/Principal | - |
Formación de Thomas A. Dix.
| Wayne State University (Michigan) | Doctorate Degree |
| The Pennsylvania State University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas A. Dix
